Summary by Moomoo AI
Sanjin Pharmaceutical released the monthly securities changes report for December 2024 on January 2, 2025. The report shows that the company canceled 21,227,000 treasury shares during the month, reducing the total number of issued shares from 2,416,800,912 to 2,395,573,912 shares.The company's legal capital remains unchanged at 0.5 billion USD, consisting of 50 billion shares of common stock with a par value of 0.00001 USD per share. In addition, there are still 16,486,000 unexercised Options under the company's stock option plan, with an exercise price of HKD 7.62 per share.The cancellation of these treasury shares reflects the company's adjustment of its equity structure, which may aim to optimize the equity structure or enhance the value per share. However, the specific reasons and the impact on the company's future development need to be evaluated further based on additional company statements or financial reports.